Brigitte Mlineritsch

6.7k citations

71 papers · 2.9k indexed · h-index 25

Impact in

Oncology top 1%
- Bone health and treatments
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Risks and Factors
Cancer Research top 1%
- Breast Cancer Treatment Studies

Papers in ⓘ

Cancer Research 38
- Breast Cancer Treatment Studies 31
Oncology 52
- Cancer Treatment and Pharmacology 24
- HER2/EGFR in Cancer Research 14
- Bone health and treatments 9
- Cancer Risks and Factors 5
- Colorectal Cancer Treatments and Studies 4

Co-authors: Michael Gnant (41 shared papers)R. Jakesz (37 shared papers)Richard Greil (49 shared papers)W. Kwasny (14 shared papers)Christian Menzel (8 shared papers)G. Luschin-Ebengreuth (14 shared papers)E. Kubista (15 shared papers)Michael Seifert (13 shared papers)
Journals: Journal of Clinical Oncology (18 papers)Cancer Research (8 papers)Annals of Oncology (3 papers)Breast Cancer Research and Treatment (3 papers)The Lancet Oncology (3 papers)
Partner nations: Austria United States Germany

In The Last Decade

Brigitte Mlineritsch

69 papers receiving 2.8k citations

Peers

Countries citing papers authored by Brigitte Mlineritsch

Since Specialization

Citations

This map shows the geographic impact of Brigitte Mlineritsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brigitte Mlineritsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brigitte Mlineritsch more than expected).

Fields of papers citing papers by Brigitte Mlineritsch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brigitte Mlineritsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brigitte Mlineritsch. The network helps show where Brigitte Mlineritsch may publish in the future.

Co-authors

The 25 scholars most cited alongside Brigitte Mlineritsch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Brigitte Mlineritsch Line = papers co-authored together Brigitte Mlineritsch links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial The Lancet Oncology ·Michael Gnant, Brigitte Mlineritsch, Herbert Stoeger, G. Luschin-Ebengreuth, Dietmar Heck, Christian Menzel, R. Jakesz, Michael Seifert, Michael Hubalek, Gunda Pristauz, Thomas Bauernhofer, Holger Eidtmann, W. Eiermann, Guenther G. Steger, W. Kwasny, Peter Dubsky, Gerhard Hochreiner, Ernst-Pius Forsthuber, Christian Fesl, Richard Greil	2011	335
2	Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy The Lancet Oncology ·Michael Gnant, Brigitte Mlineritsch, G. Luschin-Ebengreuth, Franz Kainberger, H. Kässmann, Jutta Claudia Piswanger-Sölkner, Michael Seifert, Ferdinand Ploner, Christian Menzel, Peter Dubsky, Florian Fitzal, Vesna Bjelic‐Radisic, Günther Steger, Richard Greil, Christian Marth, E. Kubista, Hellmut Samonigg, Peter Wohlmuth, Martina Mittlböck, R. Jakesz	2008	278
3	Zoledronic Acid Prevents Cancer Treatment–Induced Bone Loss in Premenopausal Women Receiving Adjuvant Endocrine Therapy for Hormone-Responsive Breast Cancer: A Report From the Austrian Breast and Colorectal Cancer Study Group Journal of Clinical Oncology ·Michael Gnant, Brigitte Mlineritsch, G. Luschin-Ebengreuth, S. Grampp, Helmut Kaessmann, Marianne Schmid, Christian Menzel, Jutta Claudia Piswanger-Soelkner, A. Galid, Martina Mittlboeck, H. Hausmaninger, R. Jakesz	2006	249
4	Extended Adjuvant Therapy With Anastrozole Among Postmenopausal Breast Cancer Patients: Results From the Randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a JNCI Journal of the National Cancer Institute ·R. Jakesz, Richard Greil, Michael Gnant, Marianne Schmid, W. Kwasny, E. Kubista, Brigitte Mlineritsch, C. Tausch, M. Stierer, F Hofbauer, K. Edward Renner, Ch. Dadak, Ernst Rücklinger, H. Samonigg, (unknown)	2007	214
5	Randomized Adjuvant Trial of Tamoxifen and Goserelin Versus Cyclophosphamide, Methotrexate, and Fluorouracil: Evidence for the Superiority of Treatment With Endocrine Blockade in Premenopausal Patients With Hormone-Responsive Breast Cancer—Austrian Breast and Colorectal Cancer Study Group Trial 5 Journal of Clinical Oncology ·R. Jakesz, H. Hausmaninger, E. Kubista, Michael Gnant, Christian Menzel, Thomas Bauernhofer, Michael Seifert, K. Haider, Brigitte Mlineritsch, P. Steindorfer, W. Kwasny, Michael Fridrik, Guenther G. Steger, Viktor Wette, Hellmut Samonigg	2002	200
6	Impact of Body Mass Index on the Efficacy of Endocrine Therapy in Premenopausal Patients With Breast Cancer: An Analysis of the Prospective ABCSG-12 Trial Journal of Clinical Oncology ·Georg Pfeiler, Robert Königsberg, Christian Fesl, Brigitte Mlineritsch, Herbert Stoeger, Christian F. Singer, Sabine Pöstlberger, Guenther G. Steger, Michael Seifert, Peter Dubsky, Susanne Taucher, Hellmut Samonigg, Vesna Bjelic‐Radisic, Richard Greil, Christian Marth, Michael Gnant	2011	153
7	Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial The Lancet Oncology ·Michael Gnant, Georg Pfeiler, Günther Steger, Daniel Egle, Richard Greil, Florian Fitzal, Viktor Wette, Marija Balić, Ferdinand Haslbauer, Elisabeth Melbinger‐Zeinitzer, Vesna Bjelic‐Radisic, R. Jakesz, Christian Marth, P. Sevelda, Brigitte Mlineritsch, Ruth Exner, Christian Fesl, Sophie Frantal, Christian F. Singer	2019	152
8	Impact of pretreatment thrombocytosis on survival in primary breast cancer Thrombosis and Haemostasis ·Andreas Salat, Michael Gnant, W. Kwasny, Brigitte Mlineritsch, Rainer-Christian Menzel, Marianne Schmid, M.G. Smola, M. Stierer, Christoph Tausch, A. Galid, Günther Steger, R. Jakesz, Susanne Taucher	2003	133
9	Treatment of Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue Type With Cladribine: A Phase II Study Journal of Clinical Oncology ·Gerald Jäger, Peter Neumeister, Ruth I. Brezinschek, Thomas Hinterleitner, Wolfgang Fiebiger, Melitta Penz, Hans Neumann, Brigitte Mlineritsch, Maria DeSantis, Franz Quehenberger, Andreas Chott, Christine Beham‐Schmid, Gerald Höfler, Werner Linkesch, Markus Raderer	2002	106
10	Extended adjuvant treatment with anastrozole: Results from the Austrian Breast and Colorectal Cancer Study Group Trial 6a (ABCSG-6a) Journal of Clinical Oncology ·R. Jakesz, H. Samonigg, Richard Greil, Michael Gnant, Marianne Schmid, W. Kwasny, E. Kubista, Brigitte Mlineritsch, C. Tausch, M. Stierer	2005	101
11	miR-16-5p Is a Stably-Expressed Housekeeping MicroRNA in Breast Cancer Tissues from Primary Tumors and from Metastatic Sites International Journal of Molecular Sciences ·Gabriel Rinnerthaler, Hubert Hackl, Simon Peter Gampenrieder, Frank Hamacher, Clemens Hufnagl, Cornelia Hauser‐Kronberger, Franz Zehentmayr, Gerd Fastner, Felix Sedlmayer, Brigitte Mlineritsch, Richard Greil	2016	71
12	Pathologic Complete Response With Six Compared With Three Cycles of Neoadjuvant Epirubicin Plus Docetaxel and Granulocyte Colony-Stimulating Factor in Operable Breast Cancer: Results of ABCSG-14 Journal of Clinical Oncology ·Günther Steger, A. Galid, Michael Gnant, Brigitte Mlineritsch, Alois Lang, Christoph Tausch, Margaretha Rudas, Richard Greil, Catharina Wenzel, Christian F. Singer, A. Haid, Sabine Pöstlberger, Hellmut Samonigg, G. Luschin-Ebengreuth, W. Kwasny, Eduard Klug, E. Kubista, Christian Menzel, R. Jakesz	2007	67
13	Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24) Annals of Oncology ·Guenther G. Steger, Richard Greil, Alois Lang, Margaretha Rudas, Florian Fitzal, Brigitte Mlineritsch, Bernd Hartmann, Rupert Bartsch, Elisabeth Melbinger, Michael Hubalek, Herbert Stoeger, Peter Dubsky, Sigrun Ressler, Andreas Petzer, Christian F. Singer, (unknown), R. Jakesz, Simon Peter Gampenrieder, Christoph Zielinski, Christian Fesl, Michael Gnant	2013	57
14	Adjuvant ovarian suppression combined with tamoxifen or anastrozole, alone or in combination with zoledronic acid, in premenopausal women with hormone-responsive, stage I and II breast cancer: First efficacy results from ABCSG-12. Journal of Clinical Oncology ·Michael Gnant, Brigitte Mlineritsch, Walter Schippinger, G. Luschin-Ebengreuth, S. Poestlberger, C Menzel, R. Jakesz, E. Kubista, Christian Marth, Richard Greil	2008	50
15	Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR) Breast Cancer Research ·Simon Peter Gampenrieder, Andreas Peer, Christian Weismann, Matthias Meißnitzer, Gabriel Rinnerthaler, Johanna Webhofer, Theresa Westphal, Marina Riedmann, Thomas Meißnitzer, H. Egger, Frederike Klaassen Federspiel, Roland Reitsamer, Cornelia Hauser‐Kronberger, Katharina Stering, Klaus Hergan, Brigitte Mlineritsch, Richard Greil	2019	47
16	Randomized Trial of Tamoxifen Versus Tamoxifen Plus Aminoglutethimide as Adjuvant Treatment in Postmenopausal Breast Cancer Patients With Hormone Receptor-Positive Disease: Austrian Breast and Colorectal Cancer Study Group Trial 6 Journal of Clinical Oncology ·Marianne Schmid, R. Jakesz, Hellmut Samonigg, E. Kubista, Michael Gnant, Christian Menzel, Michael Seifert, K. Haider, Susanne Taucher, Brigitte Mlineritsch, P. Steindorfer, W. Kwasny, M. Stierer, Christoph Tausch, Michael Fridrik, Viktor Wette, Günther Steger, H. Hausmaninger	2003	46
17	The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial British Journal of Cancer ·(unknown), Michael Gnant, Georg Pfeiler, Herbert Stöger, Brigitte Mlineritsch, Florian Fitzal, Marija Balić, W. Kwasny, Michael Seifert, M. Stierer, Peter Dubsky, Richard Greil, Guenther G. Steger, H. Samonigg, Christian Fesl, R. Jakesz	2013	43
18	Hypertension as a predictive marker for bevacizumab in metastatic breast cancer: results from a retrospective matched-pair analysis. PubMed ·Simon Peter Gampenrieder, Franz Romeder, Claudia Muß, Magdalena Pircher, Sigrun Ressler, Gabriel Rinnerthaler, Rupert Bartsch, Claudia Sattlberger, Brigitte Mlineritsch, Richard Greil	2014	31
19	Mature results from ABCSG-12: Adjuvant ovarian suppression combined with tamoxifen or anastrozole, alone or in combination with zoledronic acid, in premenopausal women with endocrine-responsive early breast cancer. Journal of Clinical Oncology ·Michael Gnant, Brigitte Mlineritsch, Herbert Stoeger, G. Luschin-Ebengreuth, S. Poestlberger, P Dubsky, R. Jakesz, CF Singer, Holger Eidtmann, Richard Greil	2010	31
20	S1-2: Long-Term Follow-Up in ABCSG-12: Significantly Improved Overall Survival with Adjuvant Zoledronic Acid in Premenopausal Patients with Endocrine-Receptor–Positive Early Breast Cancer. Cancer Research ·Michael Gnant, Brigitte Mlineritsch, G. Luschin-Ebengreuth, Herbert Stoeger, Peter Dubsky, R. Jakesz, CF Singer, Holger Eidtmann, Christian Fesl, W. Eiermann, Christian Marth, Richard Greil	2011	31

About Brigitte Mlineritsch

Brigitte Mlineritsch is a scholar working on Cancer Research, Oncology, Genetics, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 71 papers that have together received 2.9k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (31 papers), Cancer Treatment and Pharmacology (24 papers), Estrogen and related hormone effects (20 papers), Advanced Breast Cancer Therapies (20 papers), HER2/EGFR in Cancer Research (14 papers), Bone health and treatments (9 papers), Cancer Risks and Factors (5 papers) and Colorectal Cancer Treatments and Studies (4 papers). The work is most often cited by research in Oncology (2.1k citations), Cancer Research (1.2k citations), Orthopedics and Sports Medicine (356 citations), Genetics (843 citations) and Radiology, Nuclear Medicine and Imaging (452 citations). Brigitte Mlineritsch has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Michael Gnant, R. Jakesz, Richard Greil, W. Kwasny, Christian Menzel, G. Luschin-Ebengreuth, E. Kubista, Michael Seifert, Marianne Schmid and Peter Dubsky. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, Breast Cancer Research and Treatment and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact